Terms: = Bone cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb AND Treatment
15 results:
1. Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).
Mill CP; Fiskus WC; DiNardo CD; Reville P; Davis JA; Birdwell CE; Das K; Hou H; Takahashi K; Flores L; Ruan X; Su X; Loghavi S; Khoury JD; Bhalla KN
Blood Cancer J; 2024 Feb; 14(1):25. PubMed ID: 38316746
[TBL] [Abstract] [Full Text] [Related]
2. Adenoid cystic carcinoma of Bartholin's gland, a case report with genomic data and literature review.
Evin C; Just PA; Borghese B; Fabiano E; Bennani S; Canny E; Marisa L; Derive N; Laurent-Puig P; Alexandre J; Durdux C
Cancer Radiother; 2023 Jun; 27(4):328-336. PubMed ID: 36759241
[TBL] [Abstract] [Full Text] [Related]
3. COX-2 strengthens the effects of acid and bile salts on human esophageal cells and Barrett esophageal cells.
Jiangang S; Nayoung K; Hongfang W; Junda L; Li C; Xuefeng B; Mingsong L
BMC Mol Cell Biol; 2022 Apr; 23(1):19. PubMed ID: 35413817
[TBL] [Abstract] [Full Text] [Related]
4. Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levels.
Lopez de Lapuente Portilla A; Ekdahl L; Cafaro C; Ali Z; Miharada N; Thorleifsson G; Žemaitis K; Lamarca Arrizabalaga A; Thodberg M; Pertesi M; Dhapola P; Bao E; Niroula A; Bali D; Norddahl G; Ugidos Damboriena N; Sankaran VG; Karlsson G; Thorsteinsdottir U; Larsson J; Stefansson K; Nilsson B
Blood; 2022 Mar; 139(11):1659-1669. PubMed ID: 35007327
[TBL] [Abstract] [Full Text] [Related]
5. mybL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
[No Abstract] [Full Text] [Related]
6. Primary intraosseous adenoid cystic carcinoma of the mandible: a comprehensive review and analysis of four new cases with emphasis on morphologic, immunophenotypic, and molecular characteristics.
Han J; Gu T; Yang X; Hu L; Xia R; Tian Z; Li J; Zhu L; Xu L; Zhang C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Mar; 123(3):365-373. PubMed ID: 28094214
[TBL] [Abstract] [Full Text] [Related]
7. miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis.
Kfir-Erenfeld S; Haggiag N; Biton M; Stepensky P; Assayag-Asherie N; Yefenof E
Oncotarget; 2017 Jan; 8(1):472-489. PubMed ID: 27888798
[TBL] [Abstract] [Full Text] [Related]
8. Metastatic Adenoid Cystic Carcinoma Mimicking Butterfly Glioblastoma: A Rare Presentation in the Splenium of the Corpus Callosum.
Garber ST; Khoury L; Bell D; Schomer DF; Janku F; McCutcheon IE
World Neurosurg; 2016 Nov; 95():621.e13-621.e19. PubMed ID: 27521725
[TBL] [Abstract] [Full Text] [Related]
9. Myths in the Diagnosis and Management of Orbital Tumors.
Gündüz K; Yanık Ö
Middle East Afr J Ophthalmol; 2015; 22(4):415-20. PubMed ID: 26692710
[TBL] [Abstract] [Full Text] [Related]
10. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.
von Holstein SL
Acta Ophthalmol; 2013 Nov; 91 Thesis 6():1-28. PubMed ID: 24893972
[TBL] [Abstract] [Full Text] [Related]
11. Alteration of the microRNA expression profile in human osteosarcoma cells transfected with APE1 siRNA.
Dai N; Zhong ZY; Cun YP; Qing Y; Chen Ch; Jiang P; Li MX; Wang D
Neoplasma; 2013; 60(4):384-94. PubMed ID: 23581410
[TBL] [Abstract] [Full Text] [Related]
12. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract] [Full Text] [Related]
13. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.
Amatschek S; Koenig U; Auer H; Steinlein P; Pacher M; Gruenfelder A; Dekan G; Vogl S; Kubista E; Heider KH; Stratowa C; Schreiber M; Sommergruber W
Cancer Res; 2004 Feb; 64(3):844-56. PubMed ID: 14871811
[TBL] [Abstract] [Full Text] [Related]
14. Oligonucleotide therapeutics: clothing the emperor.
Gewirtz AM
Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
[TBL] [Abstract] [Full Text] [Related]
15. Oncogene-targeted antisense oligodeoxynucleotides combined with chemotherapy or immunotherapy: a new approach for tumor treatment?
Nieborowska-Skórska M; Nakashima M; Ratajczak M; Steplewski Z; Calabretta B; Skórski T
Folia Histochem Cytobiol; 1994; 32(1):35-40. PubMed ID: 8026602
[TBL] [Abstract] [Full Text] [Related]
